Browse > Article

Treatment of Frey's Syndrome Patients with Botulimum Toxin A  

Park, Byung-Chan (Department of Plastic & Reconstructive surgery, College of Medicine Yeungnam University)
Ryu, Min-Hee (Department of Plastic & Reconstructive surgery, College of Medicine Yeungnam University)
Kim, Tae-Gon (Department of Plastic & Reconstructive surgery, College of Medicine Yeungnam University)
Kim, Yong-Ha (Department of Plastic & Reconstructive surgery, College of Medicine Yeungnam University)
Publication Information
Archives of Plastic Surgery / v.36, no.3, 2009 , pp. 283-288 More about this Journal
Abstract
Purpose: Frey's syndrome is a common complication after parotid surgery and characterized by gustatory sweating and flushing in the periauricular area during meals. Although a variety of methods have been proposed to prevent this postoperative problem but they have been unsatisfactory. In this article, therefore, botulinum toxin A was used to treat nine patients with Frey's syndrome and its duration effect after injection was investigated. Methods: Nine patients became the object of study about the effect of botulinum toxins as treatment of Frey's syndrome. Age of patients ranged from 25 to 78 years (mean, 43.7 years). Six of nine patients had both symptoms of gustatory sweating and flushing. And the others had only gustatory sweating symptom. Using Minor starch iodine test, the affected skin area was detected, and it was marked by $1cm^2$ sized grid appearance. After application of EMLA cream on the gustatory sweating area, botulinum toxin A was injected intracutaneously into the affected skin area ($2.5U/cm^2$). Patients were followed up from six to fifteen months (mean, about 12 months) and asked about improvement of their symptoms. Results: The treatement with botulinum toxin A took effective within two days after injection. Six months after injection, gustatory sweating disappeared completely in all patients, and five of six patients who had gustatory flushing improved in their symptom. Last follow-up, no patients complained of recurrent gustatory sweating and flushing except one. One patient, seven months after initial injection, was retreated with botulinum toxin A because of recurrence, and the result was successful. The duration of the effect after botulinum toxin A treatment was ranged from seven to thirteen months. One patient in our series experienced the upper eyelid weakness as adverse effect, but it improved spontaneously. Conclusion: Local injection of botulinum toxin A is an effective, safe and long - lasting method for treatment of Frey's syndrome. Hereafter, however, additional study will be required to evaluate the duration effect of botulinum toxin A according to frequency in use and dosage.
Keywords
Frey's syndrome; Botulinum toxin A; Minor starch-iodine test;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Guntinas-Lichius O: Management of Frey's syndrome and hypersialorrhea with botulinum toxin. Facial Plast Surg Clin North Am 11: 503, 2003   DOI   PUBMED   ScienceOn
2 Drobik C, Laskawi R: Frey's syndrome: treatment with botulinum toxin. Acta Otolaryngol 115: 459, 1995   DOI   ScienceOn
3 Drummond PD: Mechanism of gustatory flushing in Frey's syndrome. Clin Auton Res 12: 144, 2002   DOI   ScienceOn
4 Beerens AJ, Snow GB: Botulinum toxin A in the treatment of patients with Frey syndrome. Br J Surg 89: 116, 2002   DOI   ScienceOn
5 Leverstein H, van der Wal JE, Tiwari RM, van der Waal I, Snow GB: Surgical management of 246 previously untreated pleomorphic adenomas of the parotid gland. Br J Surg 84: 399, 1997   DOI   ScienceOn
6 Park ES, Kim YB, Lee YM, Yang SJ, Park CS: Prevention of Frey's syndrome by using temporoparietal fascial flap. J Korean Soc Plast Reconstr Surg 24: 580, 1997
7 Tugnoli V, Marchese Ragona R, Eleopra R, Quatrale R, Capone JG, Pastore A, Montecucco C, De Grandis D: The role of gustatory flushing in Frey's syndrome and its treatment with botulinum toxin type A. Clin Auton Res 12: 174, 2002   DOI   ScienceOn
8 Laccourreye O, Muscatelo L, Naude C, Bonan B, Brasnu D: Botulinum toxin type A for Frey's syndrome: a preliminary prospective study. Ann Otol Rhinol Laryngol 107: 52, 1998   DOI   ScienceOn
9 Dulguerov P, Quinodoz D, Cosendai G, Piletta P, Marchal F, Lehmann W: Prevention of Frey syndrome during parotidectomy. Arch Otolaryngol Head Neck Surg 125: 833, 1999   DOI   ScienceOn
10 Ford FR, Woodhall B: Phenomena due to misdirection of regenerating fibers of cranial, spinal and autonomic nerves. Arch Surg 38: 480, 1938   DOI
11 Laccourreye O, Akl E, Gutierrez-Fonseca R, Garcia D, Brasnu D, Bonan B: Recurrent gustatory sweating(Frey syndrome) after intracutaneous injection of botulinum toxin type a: incidence, management, and outcome. Arch Otolaryngol Head Neck Surg 125: 283, 1999   DOI   ScienceOn
12 Bjerkhoel A, Trobbe O: Frey's syndrome: treatment with botulinum toxin. J Laryngol Otol 111: 839, 1997   PUBMED
13 Eckardt A, Kuettner C: Treatment of gustatory sweating (Frey's syndrome) with botulinum toxin A. Head Neck 25: 624, 2003   DOI   ScienceOn
14 Bakke M, Max Thorsen N, Bardow A, Dalager T, Eckhart Thomsen C, Regeur L: Treatment of gustatory sweating with low-dose botulinum toxin A: a case report. Acta Odontol Scand 64: 129, 2006   DOI   ScienceOn
15 Laskawi R, Drobik C, Sch$\ddot{o}$nebeck C: Up-to-date report of botulinum toxin type A treatment in patients with gustatory sweating(Frey's syndrome). Laryngoscope 108: 381, 1998   DOI   ScienceOn